SciBase CEO Simon Grant gives a comment regarding the collaboration with Johnson & Johnson Consumer Health
STOCKHOLM, SWEDEN - November 8, 2022 – SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders announced on Monday November 7 that it has initiated a collaboration with Johnson & Johnson Consumer Health Inc. to develop a unique AI-based screening tool to predict the development of a common type of eczema called atopic dermatitis in infants.Link to press release from November 7[th]: http://investors.scibase.se/en/scibase-announces-collaboration-to-detect-skin-barrier-dysfunction-in-infants Simon Grant, CEO of SciBase
